Antineoplastic Combined Chemotherapy ProtocolsCryoglobulinemiaCyclophosphamide
Dr. Mark R. Huber, MD
NPI1750357299PAC ID2466489299
- Medicare services, 2024
- 2,508
- Medicare patients, 2024
- 578
- Part D claims, 2024
- 2,736
- Publications
- 2
- Clinical trials
- 5
- Practice address
- 300 South Bruce Street, Marshall, MN 56258
- Practice phone
- Call (507) 537-9661
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Huber's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark R. Huber is a hematologist and oncologist in Marshall, Minnesota
Dr. Huber practices at Avera Marshall Regional Medical Center in Marshall, Minnesota, part of Avera Health.
Dr. Huber's NPI, 1750357299, was assigned on February 24, 2006. Dr. Huber graduated from Medical College of Georgia School of Medicine in 1999. Dr. Huber holds South Dakota license 5612.
NPI and contact details
- NPI
- 1750357299NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2466489299
- NPI enumeration date
- February 24, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (507) 537-9661
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark R. Huber practices at Avera Marshall Regional Medical Center in Marshall, Minnesota
Dr. Huber's primary practice is Avera Marshall Regional Medical Center, at 300 South Bruce Street, Marshall, MN 56258 in Lyon County. The practice phone is (507) 537-9661.
- Avera Marshall Regional Medical Center300 South Bruce Street, Marshall, MN 56258 · Lyon CountyPhone(507) 537-9661
Source: Dmand AI Affiliation Data
Dr. Mark R. Huber is affiliated with 11 sites of care and 3 medical groups
Dr. Huber's primary practice is Avera Marshall Regional Medical Center in Marshall, Minnesota, part of Avera Health. Dr. Huber is also affiliated with Avera McKennan Hospital & University Health Center. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Huber to 3 more hospitals, 3 group practices and clinics, 2 medical groups, 1 breast imaging center, 1 home health agency and 1 hospice, each named with a free account.
Avera McKennan Hospital & University Health CenterAvera McKennan Hospital & University Health Center3 hospitalsNames with a free account3 group practices and clinicsNames with a free account2 medical groupsNames with a free account1 breast imaging centerName with a free account1 home health agencyName with a free account1 hospiceName with a free account
See all 14 affiliations for Dr. HuberSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark R. Huber's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huber practices, 11 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Avera Marshall Regional Medical Center | Available with a free account |
| +10 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Huber practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Avera Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark R. Huber is one of 213 hematologists and oncologists in Minnesota
Hematology and oncology is Dr. Huber's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Huber is licensed in South Dakota.
Specialties and state licenses
- Hematology and oncology, South DakotaPrimary
Hematologists and oncologists near Dr. Huber
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark R. Huber billed Medicare for 2,508 services in 2024
CMS data shows 2,508 Medicare services from Dr. Huber across 8 procedure codes in 2024, for 578 Medicare patients. Medicare paid $120,437 for them.
Medicare services, 20242,508
Medicare patients578
Paid by Medicare$120,437
Procedure codes8
Dr. Huber's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,8452024: 1,54916%
- Other services
- 2023: 02024: 959
- Tests and treatments
- 2023: 122024: 0100%
- Surgery
- 2023: 152024: 0100%
Where Dr. Huber's Medicare services took place, 2024
- In an office1,07643%
- In a facility1,43257%
Dr. Huber compared with the Minnesota median for hematologists and oncologists, 2024
- Dr. Huber
- Minnesota median
- Medicare services
- 2,508vs 3846.5 times
- Medicare patients
- 578vs 1503.9 times
- Part D claims
- 2,485vs 3287.6 times
Medians across 209 hematologists and oncologists in Minnesota with Dmand AI profiles that report each measure.
Dr. Huber's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Huber?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Huber and other hematologists and oncologists in Minnesota.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark R. Huber treated 578 Medicare patients in 2024, average age 75
CMS counts 578 Medicare patients who saw Dr. Huber in 2024. The largest group is 65 to 74, with 266 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Huber's median patient age at 71, with 46% women.
Medicare patients, 2024578
Average age75
Average risk score2.26
Also on Medicaid7%
Dr. Huber's Medicare patients by age, 2024
Dr. Huber's Medicare patients by sex, 2024
- Women25444%
- Men32456%
Chronic conditions among Dr. Huber's Medicare patients, 2024
- High blood pressure75%
- High cholesterol66%
- Cancer61%
- Arthritis39%
- Chronic kidney disease34%
- Diabetes32%
- Ischemic heart disease30%
- COPD26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Huber's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women46%
- Men54%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark R. Huber wrote 2,736 Medicare Part D claims in 2024
In 2024, Dr. Huber wrote 2,736 Medicare Part D claims for 381 patients. 69% of them were for generic drugs. CMS names the drug for 2,485 of them, across 64 drugs with 11 or more claims each, at $9,182,932 in total drug cost. In 2023, CMS named 2,517 claims across 54 drugs.
Part D claims, 20242,736
Drugs named by CMS64
Total drug cost$9.2M
Part D patients381
Dr. Huber's Part D claims by kind of drug, 2024
- Generic1,890 claims69%
- Brand-name846 claims31%
Dr. Huber's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Huber's Part D claims, 2024
- Opioids6%155 of 2,736 claims
- Antibiotics3%87 of 2,736 claims
- Antipsychotics, patients 65 and over2%60 of 2,736 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,5172024: 2,4851%
Drugs named by CMS: 64 in 2024, 54 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mark R. Huber offers telehealth to Medicare patients
Dr. Huber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Huber as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Huber by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark R. Huber has 2 publications on record
Dmand AI links 2 papers to Dr. Huber. Dr. Huber has published most often in S D Med. Dr. Huber's most frequent co-authors are Vasantha Lakshmi Gali, MD and Ashwani Kumar Singal, MD, MS.
Papers2
Dr. Huber's most frequent co-authors
Recent publications by Dr. Huber
Acute Kidney InjuryAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunological
See who Dr. Huber researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Huber works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark R. Huber has worked on 5 clinical trials
Dmand AI links Dr. Huber to 5 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Gliosarcoma. Alliance for Clinical Trials in Oncology sponsors the most, 3.
Clinical trials with Dr. Huber by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Huber's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Gliosarcoma
- Prostatic Neoplasms
- Glioblastoma
Investigators on the most trials with Dr. Huber
- David Jon Tamura, MD3 shared trials
- Eric J. Avery, MD2 shared trials
- Manish S. Bhandari, MD2 shared trials
Recent clinical trials with Dr. Huber
CASPAR - a Phase III Trial of Enzalutamide and Rucaparib As a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (opens in a new tab)
Active, not recruitingPhase 3
Prostatic NeoplasmsProstatic DiseasesEnzalutamideDegarelixGoserelin Acetate
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas (opens in a new tab)
Status unknownPhase 2
Radiation therapyFOLFOXmFOLFIRINOX
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicPembrolizumabPegilodecakin
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicNivolumabPegilodecakin
GliosarcomaGlioblastomaBevacizumabHSPPC-96
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mark R. Huber received $1,195 in industry payments from 2016 to 2025
CMS Open Payments shows 13 general payments to Dr. Huber from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Sirtex Medical Inc paid the most, $1,000. It also lists 1 research payment totaling $190 in 2018.
General payments to Dr. Huber by program year, 2016 to 2025
General payments to Dr. Huber by kind, 2016 to 2025
$1.2Kin total
- Speaker and faculty fees$1,00084%
- Education$15713%
- Food and beverage$383%
Companies that paid Dr. Huber the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark R. Huber graduated from Medical College of Georgia School of Medicine
Dr. Huber graduated from Medical College of Georgia School of Medicine in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark R. Huber's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark R. Huber
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark R. Huber's NPI number?
Dr. Mark R. Huber's NPI number is 1750357299. It was assigned on February 24, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark R. Huber?
Dr. Mark R. Huber is a hematologist and oncologist in Marshall, Minnesota. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mark R. Huber practice?
Dr. Huber practices at 300 South Bruce Street, Marshall, MN 56258. Dr. Huber's primary practice is Avera Marshall Regional Medical Center in Marshall, Minnesota, part of Avera Health. Dmand AI also links Dr. Huber to 3 hospitals, 3 group practices and clinics, 2 medical groups, 1 breast imaging center, 1 home health agency and 1 hospice.
What is Dr. Mark R. Huber's office phone number?
The practice phone on file for Dr. Huber is (507) 537-9661.
What is Dr. Mark R. Huber's medical license number?
Dr. Huber holds South Dakota license 5612.
Which hospitals is Dr. Mark R. Huber affiliated with?
Dr. Huber practices at Avera Marshall Regional Medical Center in Marshall, Minnesota. Dr. Huber is also affiliated with Avera McKennan Hospital & University Health Center. Dmand AI links Dr. Huber to 3 more hospitals.
What medical group is Dr. Mark R. Huber part of?
Dr. Huber is linked to Avera McKennan Hospital & University Health Center. Dmand AI links Dr. Huber to 2 more medical groups.
Does Dr. Mark R. Huber accept Medicare?
Yes. CMS data shows Dr. Huber billed Medicare for 2,508 services in 2024, and Dr. Huber accepts Medicare assignment.
Does Dr. Mark R. Huber offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Huber as offering telehealth services.
How many Medicare patients does Dr. Mark R. Huber see?
CMS counts 578 Medicare patients who saw Dr. Huber in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Mark R. Huber bill to Medicare?
In 2024, Dr. Huber's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99213).
Where did Dr. Mark R. Huber go to medical school?
Dr. Huber graduated from Medical College of Georgia School of Medicine in 1999.
What drugs does Dr. Mark R. Huber prescribe most?
In 2024 Medicare Part D data, Dr. Huber's most prescribed drugs by claims were Levothyroxine Sodium, Prednisone and Acyclovir.
Has Dr. Mark R. Huber received payments from drug or device companies?
CMS Open Payments shows $1,195 in general payments to Dr. Huber from 8 companies from 2016 to 2025. The largest total came from Sirtex Medical Inc.
How long has Dr. Mark R. Huber been practicing?
Dr. Huber graduated from medical school in 1999, 27 years ago.
Does Dr. Mark R. Huber do research?
Dmand AI links 2 publications to Dr. Huber. Dr. Huber has worked on 5 clinical trials.
Who does Dr. Mark R. Huber publish with?
Dr. Huber's most frequent co-authors are Vasantha Lakshmi Gali, MD (1 shared paper) and Ashwani Kumar Singal, MD, MS (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Minnesota by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card